The ability to provide safe, urgent and integrated care is fundamental to the future
delivery of the health and social care system. We need information to follow the
patient along their pathway, so clinicians and patients can have access to the right
information at the right time. In addition, commissioners need to be able to link patient information across multiple settings to improve the services provided to their population. This needs an underpinning primary identifier across the system - the NHS Number (NHSN)
PYA Offers Regulatory Updates and Operational Implications of Meaningful UsePYA, P.C.
PYA executives Linda ClenDening and Erin Phillips recently addressed the Nashville MGMA, providing regulatory updates on the CMS meaningful use attestation process. They also shared perspectives on the operational implications of “meaningful use” for physician practices.
Meaningful Use in 2015: 6 things to do before the year’s endCureMD
What's in these slides?
1 ) Implementation timeline and requirements.
2 ) What measures have made it to the final list and how to achieve them?
3 ) A checklist of things to do before the year’s end.
4 ) What to expect from stage 3?
Customers routinely buy products for all sorts of uses. A statutory definition of a medical
device based on whether and how customers actually use products for medical purposes
would be utterly impossible to administer, and frankly unfair. The statute potentially imposes significant regulatory obligations on the seller of a product, and making those obligations depend on the whim of the customer would take compliance completely outside of the control of the seller. So instead, under the statute, it is the seller’s intent with regard to how the customer should use the product that controls how the device is regulated, not how the customer actually does use the product.
Source: http://mobihealthnews.com/wp-content/pdf/FDA_Regulation_of_Mobile_Health_2013.pdf
PYA Offers Regulatory Updates and Operational Implications of Meaningful UsePYA, P.C.
PYA executives Linda ClenDening and Erin Phillips recently addressed the Nashville MGMA, providing regulatory updates on the CMS meaningful use attestation process. They also shared perspectives on the operational implications of “meaningful use” for physician practices.
Meaningful Use in 2015: 6 things to do before the year’s endCureMD
What's in these slides?
1 ) Implementation timeline and requirements.
2 ) What measures have made it to the final list and how to achieve them?
3 ) A checklist of things to do before the year’s end.
4 ) What to expect from stage 3?
Customers routinely buy products for all sorts of uses. A statutory definition of a medical
device based on whether and how customers actually use products for medical purposes
would be utterly impossible to administer, and frankly unfair. The statute potentially imposes significant regulatory obligations on the seller of a product, and making those obligations depend on the whim of the customer would take compliance completely outside of the control of the seller. So instead, under the statute, it is the seller’s intent with regard to how the customer should use the product that controls how the device is regulated, not how the customer actually does use the product.
Source: http://mobihealthnews.com/wp-content/pdf/FDA_Regulation_of_Mobile_Health_2013.pdf
Overcoming Barriers to Scale in Digital TherapeuticsChris Hogg
Presentation at Clinically Validated DTx Conference in Boston (November 2019). What paths have DTx products taken toward commercialization, what are the barriers, what is changing?
How Data Visualization Can Help You Beat FraudHMS Healthcare
A recent HMS presentation provides insight into how data visualization can be a game-changing tool. Three case studies show how you can communicate fraud findings to prosecutors, jurors, and even defendants to protect your organization.
The Evolving Role of the Compliance Officer in the Age of Accountable CarePYA, P.C.
Much has been written about new competencies physicians must develop in the face of payment and delivery system reform. But providers are not the only ones seeing their roles change. Compliance officers, who serve as organizations’ internal police officers, will have many new challenges. PYA Principal Martie Ross presented a national Health Care Compliance Association (HCCA) webinar entitled “The Evolving Role of the Compliance Officer In the Age of Accountable Care.”
Implementation of a Perioperative Surgical Home (PSH)Wellbe
The PSH is a patient-centered, physician-led system of coordinated care that guides patients through the entire surgical experience. From the decision for surgery to 30-90 days post discharge from a medical facility, the PSH model of care is re-engineered to improve patient care and outcomes while decreasing total cost. Learn how your physicians can earn financial incentives from both the PSH and the new CMS requirements for Alternative Payment Models (APMs).
What does SGR Reform and PSH have in common? Dr. Mike Schweitzer, a national leader in PSH, will show you how physicians can leverage a PSH to meet the new APM requirements. The Medicare Access and CHIP Reauthorization Act (MACRA) replaces SGR with a new performance-based payment system and financial incentives for participation in alternative payment models. The law requires that major changes occur by January 1, 2017 – the measurement year for penalties and rewards in 2019. Dr. Schweitzer will describe how to develop a PSH program in your organization. He will share strategies to engage physician leaders to prepare for MACRA or Value Based Payments through PSH.
This webinar will enable you to:
- Identify the burning platform for a PSH
- Define the elements of a PSH
- Outline the infrastructure needed to implement a PSH
- Build and sustain the metrics to support a PSH
- Learn how to engage physician champions
About the Speaker:
Dr. Mike Schweitzer is the Vice President of Healthcare Delivery Transformation at VHA Southeast in Tampa, FL. Mike is also the Medical Director guiding the ASA-sponsored Perioperative Surgical Home Collaborative involving 44 healthcare organizations across the nation. Dr. Schweitzer is a nationally recognized speaker and has published many articles on the Perioperative Surgical Home.
Dr. Schweitzer previously served as the Chief Medical Officer for Northeast Baptist Hospital in San Antonio, TX where he was involved in the CMS Pilot for Acute Care Episodes, ACO development, and co-management programs.
Accelerate Healthy Outcomes with Data and AICognizant
Learn how leading healthcare organizations are accelerating decision making, improving business processes, enhancing user engagement, reducing costs and driving remarkable growth and profitability.
Using the Perioperative Surgical Home as a Model to Implement CJRWellbe
Watch the webinar on youtube: https://youtu.be/rNaU_P2mHXE
The transition to value-based care models has increased pressure to deliver high quality and cost effective care. The medical home concept has gained traction in the primary care setting, and now, the perioperative surgical home has the potential to improve patient satisfaction, outcomes, and cost-effectiveness in the acute setting.
Dr. Zeev Kain, Chancellor’s Professor of Anesthesiology and former Associate Dean of Clinical Operations at University of California at Irvine Health, will share challenges and lessons learned implementing their Joint Replacement Surgical Home to provide more coordinated, standardized care.
What you’ll learn:
– An overview of the Perioperative Surgical Home model, and how it can improve outcomes while reducing cost
– Lessons learned from UC Irvine’s implementation of a Joint Replacement Surgical Home
– Considerations for implementing a Perioperative Surgical Home in your organization
About the Speaker:
Zeev N. Kain is a Chancellor’s Professor of Anesthesiology & Pediatrics & Psychiatry and the Chair of the Department of Anesthesiology & Perioperative Care at UC Irvine Health. Dr. Kain completed residency training in Pediatrics and Anesthesiology, a fellowship in Pediatric Anesthesia and was received an MBA from Columbia University. After 19 years at Yale University he joined UC Irvine Health in 2008. Dr. Kain has had continuous NIH funding since 1996 and had published over 200 publications in the peer-reviewed literature. His main research focus was stress in children undergoing surgery and invasive procedures.
Dr. Kain established the annual summit on the Perioperative Surgical Home and is a member of the steering committee of a 43 hospital collaborative on this topic. His training in Lean Six Sigma and his MBA and his management background have enabled him to embark on the quest to make the Perioperative Surgical Home ubiquitous at UC Irvine Health and to help bring this care model to institutions nationally.
Learn about 2016 trends in government and private healthcare spending, employer costs, and the patient-as-consumer movement that's spurring new provider models.
Quality and Outcome Framework (QOF) is a voluntary annual incentive programme for GPs in England, detailing practice achievement results. The primary objective of QOF is to drive the quality of primary care and reduce variations in the quality of care amongst GPs
The 2020 Hospital Outpatient Prospective Payment System (OPPS) Final Rule has been issued and changes are on the way that can affect your organization’s Medicare reimbursement.
As part of our commitment to help protect and enhance your Medicare revenue, we’ve developed this expert analysis of the FY 2020 OPPS Final Rule to quickly give you insight into the most important changes.
BESLER remains your trusted advisor and we look forward to helping you identify areas of revenue opportunity for your facility.
COVID-19 Capacity Planning Tool Live Demo and Q&AHealth Catalyst
COVID-19 has created unprecedented strain on hospital capacity and resources. For some of you, you’re already over capacity; for the rest, you know capacity challenges are coming. We are in uncharted territory, all trying to do what we can to help.
In our attempt to help healthcare systems weather the storm, we created the Capacity Planning Tool to address capacity needs throughout your healthcare system—for COVID-19 and all your other patients. We started with the Penn Med Epidemic Model and added capacity planning, starting with the scarcest resources—beds and ventilators—and then we’ll focus on the dramatic increase in the need for PPE, other respiratory equipment, and staffing.
We have already made the Capacity Planning Tool available to everyone (the tool can be found here: https://www.healthcatalyst.com/covid1...). In this session, our experts explain the tool and how it’s best leveraged.
In this demo the topics we cover include:
- What the Capacity Planning Tool is
- How the tool will evolve
- How you can use the tool
- How to get additional help if needed
- Live Q&A session with our experts
Chronic Care Management in Post-Acute/LTC SettingPYA, P.C.
PYA Principal Denise Hall and PYA Manager Lori Baker presented an educational session, “Chronic Care Management in Post-Acute/LTC Setting” to members of The Vision Group during The Society for Post-Acute and Long-Term Care Medicine’s (AMDA) Annual Conference.
SVMPharma Real World Evidence – Why NHS must embrace Real World DataSVMPharma Limited
SVMPharma Real World Evidence (RWE) – In this paper, we look at how to navigate the difficult balance between financial sustainability
and optimal performance the NHS needs to be more proactive in the collection and
analysis of Real World Data (RWD) and exploit the multiple opportunities for
commissioning RWD analysis at a local and national level . For more resources on RWE visit us at www.svmpharma.com
Overcoming Barriers to Scale in Digital TherapeuticsChris Hogg
Presentation at Clinically Validated DTx Conference in Boston (November 2019). What paths have DTx products taken toward commercialization, what are the barriers, what is changing?
How Data Visualization Can Help You Beat FraudHMS Healthcare
A recent HMS presentation provides insight into how data visualization can be a game-changing tool. Three case studies show how you can communicate fraud findings to prosecutors, jurors, and even defendants to protect your organization.
The Evolving Role of the Compliance Officer in the Age of Accountable CarePYA, P.C.
Much has been written about new competencies physicians must develop in the face of payment and delivery system reform. But providers are not the only ones seeing their roles change. Compliance officers, who serve as organizations’ internal police officers, will have many new challenges. PYA Principal Martie Ross presented a national Health Care Compliance Association (HCCA) webinar entitled “The Evolving Role of the Compliance Officer In the Age of Accountable Care.”
Implementation of a Perioperative Surgical Home (PSH)Wellbe
The PSH is a patient-centered, physician-led system of coordinated care that guides patients through the entire surgical experience. From the decision for surgery to 30-90 days post discharge from a medical facility, the PSH model of care is re-engineered to improve patient care and outcomes while decreasing total cost. Learn how your physicians can earn financial incentives from both the PSH and the new CMS requirements for Alternative Payment Models (APMs).
What does SGR Reform and PSH have in common? Dr. Mike Schweitzer, a national leader in PSH, will show you how physicians can leverage a PSH to meet the new APM requirements. The Medicare Access and CHIP Reauthorization Act (MACRA) replaces SGR with a new performance-based payment system and financial incentives for participation in alternative payment models. The law requires that major changes occur by January 1, 2017 – the measurement year for penalties and rewards in 2019. Dr. Schweitzer will describe how to develop a PSH program in your organization. He will share strategies to engage physician leaders to prepare for MACRA or Value Based Payments through PSH.
This webinar will enable you to:
- Identify the burning platform for a PSH
- Define the elements of a PSH
- Outline the infrastructure needed to implement a PSH
- Build and sustain the metrics to support a PSH
- Learn how to engage physician champions
About the Speaker:
Dr. Mike Schweitzer is the Vice President of Healthcare Delivery Transformation at VHA Southeast in Tampa, FL. Mike is also the Medical Director guiding the ASA-sponsored Perioperative Surgical Home Collaborative involving 44 healthcare organizations across the nation. Dr. Schweitzer is a nationally recognized speaker and has published many articles on the Perioperative Surgical Home.
Dr. Schweitzer previously served as the Chief Medical Officer for Northeast Baptist Hospital in San Antonio, TX where he was involved in the CMS Pilot for Acute Care Episodes, ACO development, and co-management programs.
Accelerate Healthy Outcomes with Data and AICognizant
Learn how leading healthcare organizations are accelerating decision making, improving business processes, enhancing user engagement, reducing costs and driving remarkable growth and profitability.
Using the Perioperative Surgical Home as a Model to Implement CJRWellbe
Watch the webinar on youtube: https://youtu.be/rNaU_P2mHXE
The transition to value-based care models has increased pressure to deliver high quality and cost effective care. The medical home concept has gained traction in the primary care setting, and now, the perioperative surgical home has the potential to improve patient satisfaction, outcomes, and cost-effectiveness in the acute setting.
Dr. Zeev Kain, Chancellor’s Professor of Anesthesiology and former Associate Dean of Clinical Operations at University of California at Irvine Health, will share challenges and lessons learned implementing their Joint Replacement Surgical Home to provide more coordinated, standardized care.
What you’ll learn:
– An overview of the Perioperative Surgical Home model, and how it can improve outcomes while reducing cost
– Lessons learned from UC Irvine’s implementation of a Joint Replacement Surgical Home
– Considerations for implementing a Perioperative Surgical Home in your organization
About the Speaker:
Zeev N. Kain is a Chancellor’s Professor of Anesthesiology & Pediatrics & Psychiatry and the Chair of the Department of Anesthesiology & Perioperative Care at UC Irvine Health. Dr. Kain completed residency training in Pediatrics and Anesthesiology, a fellowship in Pediatric Anesthesia and was received an MBA from Columbia University. After 19 years at Yale University he joined UC Irvine Health in 2008. Dr. Kain has had continuous NIH funding since 1996 and had published over 200 publications in the peer-reviewed literature. His main research focus was stress in children undergoing surgery and invasive procedures.
Dr. Kain established the annual summit on the Perioperative Surgical Home and is a member of the steering committee of a 43 hospital collaborative on this topic. His training in Lean Six Sigma and his MBA and his management background have enabled him to embark on the quest to make the Perioperative Surgical Home ubiquitous at UC Irvine Health and to help bring this care model to institutions nationally.
Learn about 2016 trends in government and private healthcare spending, employer costs, and the patient-as-consumer movement that's spurring new provider models.
Quality and Outcome Framework (QOF) is a voluntary annual incentive programme for GPs in England, detailing practice achievement results. The primary objective of QOF is to drive the quality of primary care and reduce variations in the quality of care amongst GPs
The 2020 Hospital Outpatient Prospective Payment System (OPPS) Final Rule has been issued and changes are on the way that can affect your organization’s Medicare reimbursement.
As part of our commitment to help protect and enhance your Medicare revenue, we’ve developed this expert analysis of the FY 2020 OPPS Final Rule to quickly give you insight into the most important changes.
BESLER remains your trusted advisor and we look forward to helping you identify areas of revenue opportunity for your facility.
COVID-19 Capacity Planning Tool Live Demo and Q&AHealth Catalyst
COVID-19 has created unprecedented strain on hospital capacity and resources. For some of you, you’re already over capacity; for the rest, you know capacity challenges are coming. We are in uncharted territory, all trying to do what we can to help.
In our attempt to help healthcare systems weather the storm, we created the Capacity Planning Tool to address capacity needs throughout your healthcare system—for COVID-19 and all your other patients. We started with the Penn Med Epidemic Model and added capacity planning, starting with the scarcest resources—beds and ventilators—and then we’ll focus on the dramatic increase in the need for PPE, other respiratory equipment, and staffing.
We have already made the Capacity Planning Tool available to everyone (the tool can be found here: https://www.healthcatalyst.com/covid1...). In this session, our experts explain the tool and how it’s best leveraged.
In this demo the topics we cover include:
- What the Capacity Planning Tool is
- How the tool will evolve
- How you can use the tool
- How to get additional help if needed
- Live Q&A session with our experts
Chronic Care Management in Post-Acute/LTC SettingPYA, P.C.
PYA Principal Denise Hall and PYA Manager Lori Baker presented an educational session, “Chronic Care Management in Post-Acute/LTC Setting” to members of The Vision Group during The Society for Post-Acute and Long-Term Care Medicine’s (AMDA) Annual Conference.
SVMPharma Real World Evidence – Why NHS must embrace Real World DataSVMPharma Limited
SVMPharma Real World Evidence (RWE) – In this paper, we look at how to navigate the difficult balance between financial sustainability
and optimal performance the NHS needs to be more proactive in the collection and
analysis of Real World Data (RWD) and exploit the multiple opportunities for
commissioning RWD analysis at a local and national level . For more resources on RWE visit us at www.svmpharma.com
From the Nexus project showcase. Presented by Dr Martin Wilson, Clinical Leader I.T., Pegasus Health and Symon McHerron, CIO, Pegasus Health at HINZ 2014, 11 November 2014, 1.45pm, Plenary Room
Healthcare ecosystem is witnessing a huge transformation lately propelled by improved care and patient outcomes as the critical drivers, in addition mobile technology and IoT are leading the way for innovation in the healthcare industry, by integration sensor network such as Beacons, NFC, RFID etc.. that will play an important roles to improvise the quality of services in Intelligent Healthcare sectors .
Lisa Annaly, Head of Provider Analytics at the Care Quality Commission, discusses lessons learned from the CQC as they have worked to monitor care quality over time.
Integrate RWE into clinical developmentIMSHealthRWES
With greater application of RWE throughout the pharmaceutical
lifecycle, learnings are emerging that offer guidance for
approaches to derive the maximum value. This article captures
the author’s experience at a leading international biotech, with
insights for smoothing RWE assimilation into clinical
development and realizing the benefits it brings.
L’immobilizzazione in caso di trauma pediatricoMario Robusti
Come utilizzare al meglio i presidi pediatrici?
Soccorrere un bambino è una delle attività più complesse e delicate fra per un soccorritore. Fortunatamente i casi in cui l’attività di soccorso traumatico riguardano un paziente in età pediatrica sono rari.
La rarità dei casi in passato ha fatto trascurare lo sviluppo di dotazioni medicali dedicate in modo specifico all’intervento sul lattante, il neonato o sul bambino.
Oggi è chiaro che il bambino non è un piccolo adulto.
Il supporto aereo nell’evacuazione medica di emergenza Degli operatori specia...Mario Robusti
Come si fornisce un valido supporto aereo nell’evacuazione medica di emergenza per gli operatori di forze speciali? Ne ha parlato il dirigente medico della Polizia di Stato il dottor Fabio Ciciliano, esperto di medicina delle catastrofi e parte del dipartimento di Protezione Civile
Il modulo sanitario nella Protezione civileMario Robusti
Benvenuti in questo episodio podcast di Rescue Press, dedicato ad approfondimenti scientifici nel mondo dell’emergenza e del soccorso. Oggi, grazie alla collaborazione con il dottor Alberto Baratta del 118 di Massa, direttore della base di Elisoccorso Pegaso 3, e alla collaborazione della HEMS Association, possiamo presentarvi un estratto dell’HEMS Congress 2019.
Dalla sessione dedicata alle attività di Protezione Civile ascolterete l’intervento integrale della dottoressa Isabella Bartoli Referente Sanitario della Regione Sicilia per le Grandi Emergenze, e direttore della SUES 118 di Catania.
Durante HEMS Congress, Bartoli ha presentato la struttura dei moduli sanitari per le maxi emergenze allestite presso i vari centri di soccorso, per fornire aiuto rapidamente in caso di calamità.
Godetevi questo intervento e ricordatevi che questo podcast è disponibile sul sito web academy.rescue.press insieme a tutte le novità del mondo del soccorso pre-ospedaliero saranno online su www.rescue.press. Vi basterà cliccare sul link e registrarvi per commentare, discutere e inviare i vostri contenuti scientifici per migliorare il mondo del soccorso, a qualsiasi livello voi ne facciate parte.
Il funzionamento della C.R.O.S.S. e il sistema di aiuto alla Regione colpita ...Mario Robusti
Benvenuti a questo episodio podcast di Rescue Press, dedicato ad approfondimenti scientifici nel mondo dell’emergenza e del soccorso. Oggi, grazie alla collaborazione con il dottor Alberto Baratta del 118 di Massa, direttore della base di Elisoccorso Pegaso 3, e alla collaborazione della HEMS Association, possiamo presentarvi un estratto dell’HEMS Congress 2019. Dalla sessione dedicata alle attività di Protezione Civile ascolterete l’intervento integrale della dottoressa Rita Rossi, del Dipartimento Interaziendale per l’emergenza sanitaria territoriale, e direttore del 118 della città metropolitana di Torino. Come direttore della CROSS di Torino, la dottoressa Rossi ha presentato nell’occasione proprio il funzionamento della C.R.O.S.S. e il sistema di aiuto alla Regione colpita da calamità.
Ascoltiamo quindi l’intervento, e vi ricordiamo che questo podcast è disponibile sul sito web academy.rescue.press e che tutte le novità del mondo del soccorso pre-ospedaliero saranno online su www.rescue.press. Vi basterà cliccare sul link e registrarvi per commentare, discutere e inviare i vostri contenuti scientifici per migliorare il mondo del soccorso, a qualsiasi livello voi ne facciate parte.
Grazie e buon ascolto.
Tubi flessibili per il settore farmaceutico e medicaleMario Robusti
Universalflex commercializza tubi tusil view per aspirazione di prodotti alimentari, cosmetici e farmaceutici.
Queso tubo supera i test di migrazione in accordo alla normativa BfR Recommendation XV & XXI Cat. 2.
Non è adatto ad essere utilizzato come materiale da innesto ed impianto in esseri viventi. Non è adatto per sangue o per altri fluidi umani.
Civil Protection Forum 2015: Draft programMario Robusti
The European Civil Protection Forum is organised by the European Commission, Directorate General Humanitarian Aid and Civil Protection (DG ECHO) every two years.
LAVORO: Bando di selezione per operatori professionali infermieristici catego...Mario Robusti
L'Ente per i Servizi Tecnico-Amministrativi di Area Vasta Sud Est ha pubblicato il 5 novembre un avviso che da 20 giorni ai potenziali candidati per entrare nelle selezioni.
EBOLA - Trasporto in E.R. solo di competenza ASLMario Robusti
Esclusi i servizi convenzionati e le associazioni per ragioni di sicurezza e attrezzature. Il documento integrale emesso dalla Regione Emilia-Romagna
www.emergency-live.com
Avviso pubblico per selezione autisti ambulanza ASUR Marche zona 5Mario Robusti
Il 25 novembre scade il termine per l'iscrizione al concorso di selezione per autisti soccorritori di ambulanza organizzato dall'Asur Marche, zona vasta numero 5, che serve a stilare una graduatoria di operatori tecnici specializzati con cui effettuare assunzioni a tempo determinato perl'area di Ascoli Piceno e San Benedetto del Tronto.
Contributors to the frequency of intense climate disasters in asia pacific co...Mario Robusti
The frequency of intense natural disasters increased notably from the 1970s to the 2000s. Around half of these events happen in Asia and Pacific Area. Intense hydrometeorological disasters and climatological disasters accounted for most of the worldwide increase in natural disasters.The Springer.com Open Access Science and Media website publish a new paper about disaster prevention and climate action. This pubblication is an indipendent evalutaion at the Asian Development Bank.
The Fire and Rescue Service Books is a guidance for organize a safe system of...Mario Robusti
Operational guidance for incidents involving hazardous material.
In everyday language "hazardous materials" means solids, liquids, or gases that can wound people, other living organisms, or damage property, or the environment. They not only include materials that are toxic, radioactive, flammable, explosive, corrosive, oxidizers, asphyxiates, biohazards, pathogen or allergen substances and organisms, but also materials with physical conditions or other characteristics that render them hazardous in specific circumstances, such as compressed gases and liquids, or hot/cold materials.
The Department for Communities & local Government, with collaboration of CFRA (Chief Fire & Rescue Adviser) publish in 2012 an interesting guideline for a bettere organization of the incident ground, following safe and correct procedure. The target of this operational guidance, about the "incident involving hazardous materials" is to provide an unvaried approach for common operational practices. This simple rules could give a better explanation about the interoperability between fire and rescue services, other emergency responders, industry experts and other relevant groups. These common principles, practices and procedures are intended to support the development of safe systems of work on the incident ground and to enhance national resilience.
This book promotes and enhance good practice within the Fire and Rescue Service and is offered as a current industry standard. It is envisaged that this will help establish high standards of efficiency and safety in the interests of employers, employees and the general public.
The Guidance, which is compiled using the best sources of information known at the date of issue, is intended for use by competent persons. The application of the guidance does not remove the need for appropriate technical and managerial judgement in practical situations with due regard to local circumstances, nor does it confer any immunity or exemption from relevant legal requirements, including by-laws.Those investigating compliance with the law may refer to this guidance as illustrating an industry standard.
This book could contain interesting suggestion that could interest also Firefighters, first responder and EMS from different country, wich not follow law, guidelines or practices from United Kingdom or Commonwealth Countries.
Major incidents involving hazardous materials in the United Kingdom are rare. Such incidents place significant demands on local fire and rescue services and often require resources and support from other fire and rescue services and emergency responders.
However smaller scale incidents involving hazardous materials are more prevalent and these may require a response from any fire and rescue service in England.
The Fire and Rescue Service Operational Guidance – Incidents involving hazardous materials provid
UNOCHA Global Humanitarian Overview. Status Report of august 2014Mario Robusti
2014 has seen a major surge in humanitarian crises around the world. Inter-agency strategic response and regional response plans now target over 76 million people in thirty-one countries compared to 52 million in December 2013. 102 million people are estimated to be in need of humanitarian assistance compared to 81 million in December 2013. Global financial requirements to cover humanitarian needs rose from US$12.9 billion in 2013 to $17.3 billion now. More and more crises are having a regional impact with a spill-over effect on countries which are already fragile.
Time is money, but how much? The Monetary Value of Response Time for AmbulanceMario Robusti
The monetary values for ambulance emergency services were calculated for two different time factors, response time, which is the time from when a call is received by the emergency medical service call-taking center until the response team arrives at the emergency scene, and operational time, which includes the time to the hospital. The study was performed in two steps. First, marginal effects of reduced fatalities and injuries for a 1-minute change in the time factors were calculated. Second, the marginal effects and the monetary values were put together to find a value per minute.
NHS review: transforming urgent and emergency care services in EnglandMario Robusti
NHS England published an update on the Urgent and Emergency Care Review, which builds on NHS England’s future vision for urgent and emergency care in Transforming urgent and emergency care services in England.
READ THE ARTICLE OF EMERGENCY-LIVE HERE:
http://www.emergency-live.com/en/health-and-safety/legislation/nhs-review-transforming-urgent-and-emergency-care-services-in-england
Flambées épidémiques de Ebola et Marburg: préparation, alerte, lutte et évalu...Mario Robusti
Ce document a pour objectif de décrire les mesures de préparation, de prévention et de lutte qui ont été mises en place avec succès au cours des épidémies précédentes.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
2. OFFICIAL
2
NHS England INFORMATION READER BOXDirectorateMedicalCommissioning OperationsPatients and InformationNursingTrans. & Corp. Ops.Commissioning StrategyFinancePublications Gateway Reference:02280Document PurposeDocument NameAuthorPublication DateTarget AudienceAdditional Circulation ListDescriptionCross ReferenceAction RequiredTiming / Deadlines(if applicable) NHS Number Survey ReportSuperseded Docs(if applicable) Contact Details for further informationDocument StatusNHS England web siteThis is a controlled document. Whilst this document may be printed, the electronic version posted on the intranet is the controlled copy. Any printed copies of this document are not controlled. As a controlled document, this document should not be saved onto local or network drives but should always be accessed from the intranetConsultationsLeeds LS2 7UE7900715057Malathi ReddyProgramme ManagerStrategic Systems & TechnologyQuarry HouseFindings from the NHS Number Survey to baseline the use of the NHS Number as the primary identifier in direct care across all NHS Trusts with recommendations and actions. N/ANHS England/P&I/SSTNovember 2014CCG Accountable Officers, Care Trust CEs, Foundation Trust CEs , NHS England Regional Directors, NHS Trust CEs, CCG Contracts Managers, Performance ManagersCCG Clinical Leads, Clinical Regional Leads, Digital Clinical Champions, Information Governance leadsN/A0Yes
3. OFFICIAL
3
Document Title: NHS Number Survey Report
Version number: 1.0
First published: November 2014
Prepared by: Gavin Bell, Malathi Reddy and Inderjit Singh
Classification: OFFICIAL
4. OFFICIAL
4
Contents
Contents ..................................................................................................................... 4
1 Executive Summary............................................................................................. 5
1.1 Context .......................................................................................................... 5
1.2 Key Findings .................................................................................................. 5
1.3 Heat-Map showing the use of the NHS Number by Trusts ............................ 7
1.4 Recommendations......................................................................................... 8
1.5 Next Steps ..................................................................................................... 8
Detailed Analysis of Survey Responses ..................................................................... 9
1.6 Levels of use of the NHS Number ................................................................. 9
1.7 Proportion of use of the NHS Number by care setting ................................. 10
1.8 Mechanism used to retrieve the NHS Number by care setting .................... 10
1.9 Benefits of using the NHS Number as the Primary Identifier ....................... 11
5. OFFICIAL
5
1 Executive Summary
1.1 Context
The ability to provide safe, urgent and integrated care is fundamental to the future delivery of the health and social care system. We need information to follow the patient along their pathway, so clinicians and patients can have access to the right information at the right time. In addition, commissioners need to be able to link patient information across multiple settings to improve the services provided to their population. This needs an underpinning primary identifier across the system - the NHS Number (NHSN).
Whilst the value of the NHS Number has been understood for a while, in order to meet the key needs of our health and social care system, the use of the NHS Number has to move from “good practice” to “core practice”. This requires the use of the NHS Number as early as possible in the care process, and established as the primary identifier when sharing information across organisations.
To further this objective, NHS England launched a survey across all NHS Trusts on their usage of the NHS Number in clinical correspondence1 that is shared across organisations. This created for the first time, a baseline of the use of the NHS Number in direct care.
This baseline information will enable commissioners to hold Providers to account on their compliance of existing NHS Standard Contract terms which states that “The Provider must use the NHS Number as the primary identifier in all clinical correspondence (paper or electronic)”. The Provider must be able to use the NHS Number to identify all activity relating to a Service User.
To support the enforcement of the NHS Standard Contract terms, we will now look to introduce new powers to Commissioners, where funding to Providers will be withheld unless these obligations are met.
1.2 Key Findings
1. The overall figure for use of the NHS Number by NHS Trusts in England as the primary identifier in clinical correspondence shared across organisations was 97.6% (239 of the 245 Trusts surveyed). This result indicates that the Secretary of State’s public commitment, for “95% of Trusts to be using the NHS number as primary identifier in clinical correspondence by the end of January 2015” has been achieved.
However, whilst meeting this public commitment, the survey responses highlighted that the NHS Number is not used consistently in clinical
1 e.g. Outpatient Letters, Discharge Summaries, A&E Letters, Out of Hours Reports, Ambulance Reports, Mental Health Discharge, Referrals. Consequently, this did not include correspondence where NHS Number is not to be included e.g. sexual health.
6. OFFICIAL
6
correspondence shared across organisations. The usage is shown in the heat map below.
2. Six Trusts (three Acute, two Ambulance and one Community) responded that the NHS Number was not used as the primary identifier in their clinical correspondence.
3. 80% of Ambulance Trusts used the NHS Number only up to 50% of their clinical correspondence.
4. 15.1% of Trusts (across all care settings) responded that they used the NHS Number only up to 75% of their clinical correspondence.
5. There is inconsistency between the survey responses received from some Trusts and their submissions of their NHS Number initiatives to the Information Governance Toolkit.
7. OFFICIAL
7
1.3 Heat-Map showing the use of the NHS Number by Trusts
The heat-map shows that low usage of the NHS Number in clinical correspondence across organisations, is not a geographically specific issue.
8. OFFICIAL
8
1.4 Recommendations
1) All commissioners should now request clear plans from their providers, for ensuring that the NHS Number is used in all clinical correspondence shared across organisations. Commissioners must hold providers to account on their existing contractual terms - with specific focus on those Trusts that are less than 75% compliant.
2) A specific follow up from the NHS Number Programme in conjunction with regional teams on those Trusts that are currently not using the NHS Number as the primary identifier should take place, so as to understand the reasons for non-compliance and to propose corrective action that must be implemented.
3) The Programme to commission the production of Guidance on different approaches to tracing and retrieving the NHS Number from the central Personal Demographics Service (PDS).
4) The Programme to publish the names of those system suppliers that are already PDS compliant with live look-up facility, so that local organisations have a clear view of which products will provide a direct link to retrieve the NHS Number.
5) NHS England to include within the digital maturity index, an explicit measure on the use of the NHS Number as the primary identifier for clinical correspondence shared across organisations.
6) A review of the Information Governance Toolkit (IGTK) requirements relating to the NHS Number (401,421 and 422).
1.5 Next Steps
The following immediate actions will be implemented:
Action Responsibility Date
Issue clear communications to the Area Teams (ATs) and Clinical Commissioning Groups (CCGs) on those Trusts that are showing <75% use of the NHS Number.
NHSN Programme
AT/CCGs
Nov ‘14
Undertake specific follow up by NHS Number Programme in conjunction with local teams on those six organisations that do not use NHS Number as primary identifier.
NHSN Programme
AT/CCGs
Nov’14
Publish Guidance on approaches for tracing and retrieval of NHS Number for all care settings.
NHSN Programme
Nov ’14
Publication of PDS compliant systems suppliers across all care settings.
NHSN Programme
Dec ‘14
Inclusion of an explicit measure in the digital maturity index on the use of the NHS Number as the primary identifier in external clinical correspondence for health and social care.
NHSN Programme
Nov ‘14
Review of the IGTK requirements 401,421 and 422.
HSCIC
Nov‘14
9. OFFICIAL
9
Detailed Analysis of the Survey Responses
1.6 Levels of use of the NHS Number
Chart 1.1 shows the levels of use of the NHS Number as the primary identifier in clinical correspondence shared across organisations.
Chart 1.1 – Levels of use of the NHS Number as the Primary Identifier in Clinical Correspondence by Trusts
Of the 245 Trusts questioned:
208 (84.9%) responded that ‘Over 75%’ of the Trust’s clinical correspondence shared across organisations contains the NHS Number
19 (7.8%) responded that coverage was between ‘51 and 75%’
5 (2%) responded that the coverage was between ‘26 and 50%’
3 (1.2%) responded that the coverage was ‘Less than 26%’
4 Trusts (1.6%) reported using the NHS Number as the primary identifier in their clinical correspondence, but were unable to provide the proportion of coverage
6 Trusts responded that they do not use the NHS Number as the primary identifier in clinical correspondence shared across organisations
10. OFFICIAL
10
1.7 Proportion of use of the NHS Number by care setting
The analysis identified the proportion of use of the NHS Number as primary identifier, broken down by care setting.
The analysis shows that 80% (8 out of 10) Ambulance Trusts use the NHS Number in less than 50% of their clinical correspondence.
Chart 1.2 - Breakdown of use of the NHS Number as the Primary Identifier in Clinical Correspondence by Organisation Type
1.8 Mechanism used to retrieve the NHS Number by care setting
Trusts were asked to list the mechanisms used for sourcing and, or checking patients’ NHS Number.
The results of the survey (shown in chart 1.3) indicate that the vast majority of Acute Trusts still rely on batch tracing as the primary mechanism. But a significant proportion supplements this with the use of the Summary Care Record/Spine portal application for real-time access to demographic information.
For Community and Ambulance Trusts, the Summary Care Record/Spine portal application is the primary mechanism used for retrieving demographic information.
11. OFFICIAL
11
Chart 1.3 - Breakdown of Mechanism(s) used to source or check the NHSN from Personal Demographics Service
1.9 Benefits of using the NHS Number as the Primary Identifier
Those Trusts reporting use of the NHS Number as the primary identifier in their clinical correspondence, were asked to consider ‘the benefits of using the NHS Number’ with choices from a drop down list. Trusts were able to provide multiple responses.
Table 1.1 shows that the two main benefits reported by most Trusts were patient safety and improved data quality.
Benefits of Using the NHS Number Trusts Identifying Benefit
Patient safety
227
Improved data quality
227
Improved patient journey through health & care
209
Reduction in costs
79
Other - Joining data across systems/organisations
14
Other - Improved data sharing/security
8
Other - Improved governance/compliance
4
Table 1.1 - Key Benefits of Using the NHSN as Primary Identifier Based on Trust Responses